Option Care, Inc.
485 Half Day Road
Suite 300
Buffalo Grove
Illinois
60089
United States
Tel: 800-879-6137
Website: http://www.optioncare.com/
15 articles about Option Care, Inc.
-
Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2022 and Announces Share Repurchase Authorization
2/23/2023
Option Care Health, Inc., the nation’s largest independent provider of home and alternate site infusion services, announced financial results for the fourth quarter and full year ended December 31, 2022.
-
Option Care Health to Announce Third Quarter 2022 Financial Results and Host Conference Call
10/4/2022
Option Care Health Inc. announced that the company will release results for its third quarter ended September 30, 2022 on Thursday, October 27, 2022 before the market opens.
-
Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2022
7/27/2022
Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced financial results for the second quarter ended June 30, 2022.
-
Option Care Health Announces Upsizing and Pricing of Secondary Offering of 15,000,000 Shares of Common Stock
2/9/2021
Option Care Health, Inc. announced that an affiliate of Madison Dearborn Partners has agreed to sell 15,000,000 shares of the Company’s common stock at a price to the public of $18.50 per share in an underwritten public offering.
-
Option Care Health to Participate in the Canaccord Genuity Virtual Growth Conference
8/5/2020
Option Care Health Inc., the nation’s largest independent national provider of home and alternate site infusion services, will present at the 40th Annual Canaccord Genuity Virtual Growth Conference on Wednesday, August 12, 2020.
-
Option Care Health Announces Preliminary Financial Results for the Second Quarter and Schedules Second Quarter Earnings Call
7/20/2020
Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today preliminary financial results for the second quarter ended June 30, 2020. Second Quarter 2020 Preliminary Financial Results For the second quarter, Option Care Health expects to report: Net revenue of approximately $740.8 million, representing comparable
-
Option Care Health Selected as Preferred Pharmacy Partner To Prepare and Distribute Breakthrough Cancer Therapy
5/21/2020
Option Care Health, Inc., the nation’s largest independent provider of home and alternate site infusion services, has been selected by UroGen Pharma as a preferred national pharmacy provider to prepare and deliver a first-of-its-kind cancer treatment, Jelmyto™ for pyelocalyceal solution.
-
Option Care Health Announces Financial Results for the First Quarter and Provides an Update on the Impact of COVID-19 Pandemic
5/7/2020
Option Care Health, Inc., the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2020.
-
Option Care Health Completes Reverse Stock Split and Ticker Symbol Change
2/3/2020
Option Care Health, Inc., the nation’s largest independent provider of home and alternate site infusion services, announced that it has completed the reverse 1-for-4 stock split of its shares of common stock, as previously disclosed in the Company’s filings with the Securities and Exchange Commission.
-
Option Care ASPEN Study Shows Clinical Interventions in Home Nutrition Patients Reduce Readmissions, Save Costs
3/21/2019
Clinical interventions provided by a nutrition support team can prevent hospital readmission in patients with short bowel syndrome receiving home parenteral nutrition, saving millions in costs annually, suggests a study¹ by Option Care Enterprises, Inc., the nation’s leading provider of home and alternate site infusion therapy services.
-
Cutting-Edge Option Care Research Presented at NHIA Finds Home IV Antibiotic Method Can Affect Adherence, Cost
3/11/2019
New research by Option Care Enterprises, Inc., the nation’s leading provider of home and alternate site infusion therapy services, suggests the method of antibiotic intravenous administration can improve patient compliance while decreasing costs.
-
Option Care Announces Second Quarter Earnings Release Date - August 9, 2005
7/19/2005
-
Option Care, Inc. Announces First Quarter Earnings Release Date - May 10, 2005
4/20/2005
-
Option Care Announces Fourth Quarter And Year-End 2004 Results; Q4 Revenues Of $113 Million; Earnings Per Diluted Share Of $0.24
2/22/2005
-
Option Care Announces Proposed Offering Of Convertible Notes
10/26/2004